226 related articles for article (PubMed ID: 15243299)
1. Roles of endothelin ETA and ETB receptors in the pathogenesis of monocrotaline-induced pulmonary hypertension.
Nishida M; Eshiro K; Okada Y; Takaoka M; Matsumura Y
J Cardiovasc Pharmacol; 2004 Aug; 44(2):187-91. PubMed ID: 15243299
[TBL] [Abstract][Full Text] [Related]
2. Role of endothelin ETB receptor in the pathogenesis of monocrotaline-induced pulmonary hypertension in rats.
Nishida M; Okada Y; Akiyoshi K; Eshiro K; Takoaka M; Gariepy CE; Yanagisawa M; Matsumura Y
Eur J Pharmacol; 2004 Aug; 496(1-3):159-65. PubMed ID: 15359489
[TBL] [Abstract][Full Text] [Related]
3. Activation of the right ventricular endothelin (ET) system in the monocrotaline model of pulmonary hypertension: response to chronic ETA receptor blockade.
Jasmin JF; Cernacek P; Dupuis J
Clin Sci (Lond); 2003 Dec; 105(6):647-53. PubMed ID: 12823096
[TBL] [Abstract][Full Text] [Related]
4. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats.
Cui B; Cheng YS; Dai DZ; Li N; Zhang TT; Dai Y
Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):169-75. PubMed ID: 18986320
[TBL] [Abstract][Full Text] [Related]
5. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
Nishida M; Hasegawa Y; Tanida I; Nakagawa E; Inaji H; Ohkita M; Matsumura Y
Eur J Pharmacol; 2009 Jul; 614(1-3):70-6. PubMed ID: 19379725
[TBL] [Abstract][Full Text] [Related]
6. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F
J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
[TBL] [Abstract][Full Text] [Related]
7. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension.
Miyauchi T; Yorikane R; Sakai S; Sakurai T; Okada M; Nishikibe M; Yano M; Yamaguchi I; Sugishita Y; Goto K
Circ Res; 1993 Nov; 73(5):887-97. PubMed ID: 8403258
[TBL] [Abstract][Full Text] [Related]
8. Role of the endothelin system in secondary pulmonary hypertension related to air embolism: lessons learned from testing four classes of endothelin blockers in a rat model.
Battistini B; Verreault M; Ayach B; Blouin A; Cernacek P; Jeng AY; Wessale J; Opgenorth T; Tsang J
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S386-9. PubMed ID: 15838327
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-1 is elevated in monocrotaline pulmonary hypertension.
Frasch HF; Marshall C; Marshall BE
Am J Physiol; 1999 Feb; 276(2):L304-10. PubMed ID: 9950893
[TBL] [Abstract][Full Text] [Related]
10. Defective intracellular calcium handling in monocrotaline-induced right ventricular hypertrophy: protective effect of long-term endothelin-A receptor blockade with 2-benzo[1,3]dioxol-5-yl-3-benzyl-4-(4-methoxy-phenyl-)- 4-oxobut-2-enoate-sodium (PD 155080).
Brunner F; Wölkart G; Haleen S
J Pharmacol Exp Ther; 2002 Feb; 300(2):442-9. PubMed ID: 11805203
[TBL] [Abstract][Full Text] [Related]
11. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
Matsumura Y; Hashimoto N; Taira S; Kuro T; Kitano R; Ohkita M; Opgenorth TJ; Takaoka M
Hypertension; 1999 Feb; 33(2):759-65. PubMed ID: 10024341
[TBL] [Abstract][Full Text] [Related]
12. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
[TBL] [Abstract][Full Text] [Related]
13. The orally active ET(A) receptor antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphe nyl-propionic acid (LU 135252) prevents the development of pulmonary hypertension and endothelial metabolic dysfunction in monocrotaline-treated rats.
Prié S; Leung TK; Cernacek P; Ryan JW; Dupuis J
J Pharmacol Exp Ther; 1997 Sep; 282(3):1312-8. PubMed ID: 9316840
[TBL] [Abstract][Full Text] [Related]
14. Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats.
Hill NS; Warburton RR; Pietras L; Klinger JR
J Appl Physiol (1985); 1997 Oct; 83(4):1209-15. PubMed ID: 9338430
[TBL] [Abstract][Full Text] [Related]
15. Change in pharmacological effect of endothelin receptor antagonists in rats with pulmonary hypertension: role of ETB-receptor expression levels.
Sauvageau S; Thorin E; Villeneuve L; Dupuis J
Pulm Pharmacol Ther; 2009 Aug; 22(4):311-7. PubMed ID: 19489130
[TBL] [Abstract][Full Text] [Related]
16. Nonselective ETA/ETB-receptor blockade increases systemic blood pressure of Bio 14.6 cardiomyopathic hamsters.
Honoré JC; Carrier E; Fecteau MH; Tirapelli CR; Bkaily G; D'Orleans-Juste P
Can J Physiol Pharmacol; 2008 Jun; 86(6):394-401. PubMed ID: 18516103
[TBL] [Abstract][Full Text] [Related]
17. Localization and distribution of endothelin receptor subtypes in pulmonary vasculature of normal and hypoxia-exposed rats.
Soma S; Takahashi H; Muramatsu M; Oka M; Fukuchi Y
Am J Respir Cell Mol Biol; 1999 Apr; 20(4):620-30. PubMed ID: 10100993
[TBL] [Abstract][Full Text] [Related]
18. Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertension.
Ivy DD; McMurtry IF; Colvin K; Imamura M; Oka M; Lee DS; Gebb S; Jones PL
Circulation; 2005 Jun; 111(22):2988-96. PubMed ID: 15927975
[TBL] [Abstract][Full Text] [Related]
19. Aspirin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing the ERK/MAPK pathway.
Gao H; Cheng Y; Zong L; Huang L; Qiao C; Li W; Gong B; Hu J; Liu H; Wang X; Zhao C
Clin Exp Hypertens; 2017; 39(1):34-41. PubMed ID: 28055284
[TBL] [Abstract][Full Text] [Related]
20. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
